Proper Name: ADAMTS13, recombinant-krhn
Manufacturer: Takeda Pharmaceuticals U.S.A., Inc.
- Prophylactic or on-demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP)
- November 9, 2023 Approval Letter - ADZYNMA
- November 9, 2023 Summary Basis for Regulatory Action - ADZYNMA